Patents by Inventor Maria Conceicao Figueiredo

Maria Conceicao Figueiredo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Particles with Peptide Boronic Acid or Boronate Ester Compounds and Methods of Making and Using Same
    Publication number: 20200261596
    Abstract: Disclosed herein are compositions for treating and preventing diseases such as myeloma and lymphoma, where the compositions include a biocompatible, therapeutic polymeric nanoparticle having a boronate ester compound or a peptide boronic acid compound, and a biodegradable polymer. Methods of use of the therapeutic compositions are also disclosed.
    Type: Application
    Filed: October 19, 2017
    Publication date: August 20, 2020
    Applicant: Pfizer Inc.
    Inventors: Mir Mukkaram Ali, Maria Conceicao Figueiredo, Jeffrey Hrkach, Young-Ho Song, James Wright, Stephen E. Zale
  • Therapeutic Nanoparticles Comprising A Therapeutic Agent and Methods of Making and Using Same
    Publication number: 20180311177
    Abstract: The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic base, an acidic therapeutic agent, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: October 28, 2016
    Publication date: November 1, 2018
    Applicant: Pfizer Inc.
    Inventors: Young-Ho Song, Maria Conceicao Figueiredo, David Michael DeWitt
  • Therapeutic Nanoparticles With High Molecular Weight Copolymers
    Publication number: 20180000885
    Abstract: The present disclosure generally relates to therapeutic nanoparticles. Exemplary nanoparticles disclosed herein may include about 0.1 to about 40 weight percent of a therapeutic agent and about 10 to about 90 weight percent a diblock poly(lactic) acid-poly(ethylene)glycol copolymer or a diblock poly(lactic)-co-poly(glycolic) acid-poly(ethylene)glycol copolymer, wherein the diblock poly(lactic) acid-poly(ethylene)glycol copolymer comprises poly(lactic) acid having a number average molecule weight of about 30 kDa to about 90 kDa or the diblock poly(lactic)-co-poly(glycolic) acid-poly(ethylene)glycol copolymer comprises poly(lactic)-co-poly(glycolic) acid having a number average molecule weight of about 30 kDa to about 90 kDa.
    Type: Application
    Filed: June 15, 2017
    Publication date: January 4, 2018
    Applicant: Pfizer Inc.
    Inventors: David Dewitt, Maria Conceicao Figueiredo, Hong Wang, Gregory Troiano, Young-Ho Song